• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by FutureTech II Acquisition Corp.

    8/15/25 4:05:23 PM ET
    $FTII
    Blank Checks
    Finance
    Get the next $FTII alert in real time by email
    NT 10-Q 1 formnt10-q.htm NT 10-Q

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 12b-25

     

      NOTIFICATION OF LATE FILING SEC FILE NUMBER
    001-41497
         
        CUSIP NUMBER
        27877D104

     

    (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR

     

      For Period Ended: June 30, 2025
       
      ☐ Transition Report on Form 10-K
      ☐ Transition Report on Form 20-F
      ☐ Transition Report on Form 11-K
      ☐ Transition Report on Form 10-Q
      ☐ Transition Report on Form N-SAR
       
      For the Transition Period Ended:________________________

     

    Read attached instruction sheet before preparing form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
     
     

    PART I - REGISTRANT INFORMATION

     

     
    Full Name of Registrant
     
    FutureTech II Acquisition Corp.
    Former Name if Applicable
     
     
    Address of Principal Executive Office (Street and Number)
     
    128 Gail Drive
    City, State and Zip Code

     

    New Rochelle, NY 10805

     

     

     

     
     

     

    PART II

    RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

    ☒ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K, Form N-SAR or From N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
    (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III

    NARRATIVE

     

    State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    FutureTech II Acquisition Corp. (the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense due to the reasons described below. The management of the Company has been working diligently to complete all of the required information for the Form 10-Q, and a substantial part of such information has been completed as of this date. However, the Company requires additional time to prepare, review and finalize its financial statements to be included in the Form 10-Q.

     

    PART IV

    OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification
       
      Ray Chen   (914)   316-4805
      (Name)   (Area Code)   (Telephone Number)

     

    (2)

    Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months (or for such shorter) period that the registrant was required to file such reports) been filed? If answer is no, identify report(s).

     

    ☒ Yes ☐ No

       
    (3)

    Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

     

    ☒ Yes ☐ No

     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    Based on preliminary information, primarily as a result of a material decrease in investment income, the Company expects to report a net loss for the three months ended June 30, 2025, which will be greater than the loss for the three months ended June 30, 2024 and a net loss for the six months ended June 30, 2025 as compared to net income for the six months ended June 30, 2024.

     

    2

     

     

      FutureTech II Acquisition Corp.  
      (Name of Registrant as Specified in Charter)  

     

    Has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: August 15, 2025 By: /s/ Ray Chen
      Name: Ray Chen
      Title: CEO

     

    INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

     

      ATTENTION  
       
    Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

     

    3

     

    Get the next $FTII alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FTII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FTII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO & CFO Chen Ray Lei converted options into 380,000 shares (SEC Form 4)

    4 - FutureTech II Acquisition Corp. (0001889450) (Issuer)

    2/6/25 8:42:18 PM ET
    $FTII
    Blank Checks
    Finance

    Large owner Radu Zachary C. converted options into 2,445,000 shares (SEC Form 4)

    4 - FutureTech II Acquisition Corp. (0001889450) (Issuer)

    2/6/25 6:30:25 PM ET
    $FTII
    Blank Checks
    Finance

    Director Bush Neil converted options into 10,000 shares (SEC Form 4)

    4 - FutureTech II Acquisition Corp. (0001889450) (Issuer)

    2/6/25 4:48:44 PM ET
    $FTII
    Blank Checks
    Finance

    $FTII
    SEC Filings

    View All

    SEC Form 10-Q filed by FutureTech II Acquisition Corp.

    10-Q - FutureTech II Acquisition Corp. (0001889450) (Filer)

    8/22/25 5:10:57 PM ET
    $FTII
    Blank Checks
    Finance

    FutureTech II Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - FutureTech II Acquisition Corp. (0001889450) (Filer)

    8/18/25 5:26:57 PM ET
    $FTII
    Blank Checks
    Finance

    FutureTech II Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - FutureTech II Acquisition Corp. (0001889450) (Filer)

    8/15/25 6:41:34 PM ET
    $FTII
    Blank Checks
    Finance

    $FTII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

    New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the "Company") (NASDAQ:FTII), today announced that it received an expected deficiency notification letter from the staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") on November 27, 2024 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the "Q3 10-Q"), as described more fully in the Company's Form 12b-25 Notification of Late Filing filed with the Securities and Exchange Commission (the "SEC") on November 15, 2024. Th

    12/4/24 1:35:00 PM ET
    $FTII
    Blank Checks
    Finance

    Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

     -Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of longevity-related products and services designed to increase the health span for the rapidly growing global aging population.    -Late-stage, diversified pipeline of therapeutic candidates across ophthalmology, cardiovascular disease and soft tissue reconstruction and repair.    -Near-term clinical milestones include Phase 3 start for LBI-201 for Ischemic stroke, Phase 2 data for LBI-101 for soft-tissue reconstruction, and Phase 2 start for LBI-001 in retinal vein occlusion.    -Seasoned management team of m

    9/20/24 2:55:00 PM ET
    $FTII
    Blank Checks
    Finance

    FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

    New Rochelle, NY, May 17, 2023 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (NASDAQ:FTIIU) (the "Company"), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, announced today that it caused to be deposited $1,150,000 into the Company's trust account for its public stockholders, representing $0.10 per public share, allowing the Company to extend by three months (from May 18, 2023 to August 18, 2023) the period of time the Company has to consummate its initial business combination (the "Extension"). The Extension is the second of two

    5/17/23 4:05:00 PM ET
    $FTII
    Blank Checks
    Finance

    $FTII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

    SC 13G/A - FutureTech II Acquisition Corp. (0001889450) (Subject)

    11/14/24 1:07:48 PM ET
    $FTII
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

    SC 13G/A - FutureTech II Acquisition Corp. (0001889450) (Subject)

    11/13/24 4:51:36 PM ET
    $FTII
    Blank Checks
    Finance

    SEC Form SC 13G filed by FutureTech II Acquisition Corp.

    SC 13G - FutureTech II Acquisition Corp. (0001889450) (Subject)

    11/13/24 4:41:47 PM ET
    $FTII
    Blank Checks
    Finance